{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:06:39Z","timestamp":1787036799388,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.059","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T08:00:36Z","timestamp":1564473636000},"page":"5211-5217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self\u2013controlled case-series study in England"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-2684","authenticated-orcid":false,"given":"Nick","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"355","key":"10.1016\/j.vaccine.2019.07.059_b0005","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"13","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.07.059_b0010","unstructured":"Higgins JPT, Soares-Weiser K, Reingold. Systematic review of the non-specfic effects of BCG, DTP and measles containing vaccines. Available at http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/april\/3_NSE_Epidemiology_review_Report_to_SAGE_14_Mar_FINAL.pdf?ua=1 [accessed 4th August 2018]."},{"issue":"8","key":"10.1016\/j.vaccine.2019.07.059_b0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.2014.470","article-title":"Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections","volume":"311","author":"Sorup","year":"2014","journal-title":"JAMA"},{"issue":"50","key":"10.1016\/j.vaccine.2019.07.059_b0020","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.vaccine.2016.11.005","article-title":"Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study","volume":"34","author":"Sorup","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.059_b0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/cid\/cix442","article-title":"Risk of nontargeted infectious disease hospitalizations among US children following inactivated and live vaccines, 2005\u20132014","volume":"65","author":"Bardenheier","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2019.07.059_b0030","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.vaccine.2016.06.020","article-title":"Heterologous vaccine effects","volume":"34","author":"Saadatian-Elahi","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.059_b0035","article-title":"Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands","volume":"358","author":"Tielemans","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.07.059_b0040","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.059_b0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/adc.88.3.222","article-title":"Bacterial infections, immune overload, and MMR vaccine. Measles, mumps, and rubella","volume":"88","author":"Miller","year":"2003","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.vaccine.2019.07.059_b0050","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.vaccine.2008.12.038","article-title":"No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine","volume":"27","author":"Stowe","year":"2009","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2019.07.059_b0055","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1016\/j.vaccine.2010.08.062","article-title":"Post-licensure comparison of the safety profile of diphtheria\/tetanus\/whole cell pertussis\/haemophilus influenza type b vaccine and a 5-in-1 diphtheria\/tetanus\/acellular pertussis\/haemophilus influenza type b\/polio vaccine in the United Kingdom","volume":"28","author":"Andrews","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.059_b0060","unstructured":"Health and Social Care Information Centre. Hospital Episode Statistics 2016 [Available from: http:\/\/www.hscic.gov.uk\/hes]"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.059_b0065","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.106.5.e62","article-title":"Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination","volume":"106","author":"Virtanen","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.059_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0163-4453(98)90604-1","article-title":"Hospital admissions in children due to pneumococcal pneumonia in England","volume":"37","author":"Djuretic","year":"1998","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.059_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/sim.7536","article-title":"Investigating the assumptions of the self-controlled case series method","volume":"37","author":"Whitaker","year":"2018","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.059_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-018-1004-z","article-title":"Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control","volume":"16","author":"Thorrington","year":"2018","journal-title":"BMC Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:22Z","timestamp":1759401202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19309673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":16,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19309673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self\u2013controlled case-series study in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}